Abstract:Background: Rhodanines and quinazolinones have been reported to possess various pharmacological activities. Results: A novel series of twenty quinazolinone-based rhodanines were synthesized via Knoevenagel condensation between 4-[3-(substitutedphenyl)-3,4-dihydro-4-oxoquinazolin-2-yl)methoxy]substituted-benzaldehydes and rhodanine. Elemental and spectral analysis were used to confirm structures of the newly synthesized compounds. The newly synthesized compounds were biologically evaluated for in vitro cytotoxic activity against the human fibrosarcoma cell line HT-1080 as a preliminary screen using the MTT assay. Conclusions: All the target compounds were active, displaying IC50 values roughly in the range of 10-60 µM. Structure-activity relationship study revealed that bulky, hydrophobic, and electron withdrawing substituents at the para-position of the quinazolinone 3-phenyl ring as well as methoxy substitution on the central benzene ring, enhance cytotoxic activity. The four most cytotoxic compounds namely, 45, 43, 47, and 37 were further tested against two human leukemia cell lines namely, HL-60 and K-562 and showed cytotoxic activity in the low micromolar range with compound 45 being the most active, having IC50 values of 1.2 and 1.5 μM, respectively. Interestingly, all four compounds were devoid of cytotoxicity against normal human fibroblasts strain AG01523, indicating that the synthesized rhodanines may be selectively toxic against cancer cells. Mechanistic studies revealed that the most cytotoxic target compounds exhibit pro-apoptotic activity and trigger oxidative stress in cancer cells.

Recent Advances in the Synthesis of Rosettacin

Recent Advances In The Synthesis Of Lamellarins As Anticancer Alkaloids

Total Synthesis of Camptothecins: An Update

Antitumor Agents. 274. A New Synthetic Strategy for E-ring SAR Study of Antofine and Cryptopleurine Analogues.

Design and One-Pot Synthesis of New 7-Acyl Camptothecin Derivatives As Potent Cytotoxic Agents

Synthesis and biological evaluation of new homocamptothecin analogs

Synthesis and Antitumor Activities of Novel (20S)-O-selenoacetyl Camptothecin Derivatives.

Total Synthesis of 7-Ethyl-10-hydroxycamptothecin (SN38) and Its Application to the Development of C18-functionalized Camptothecin Derivatives.

Rosavin: Research Advances in Extraction and Synthesis, Pharmacological Activities and Therapeutic Effects on Diseases of the Characteristic Active Ingredients of Rhodiola rosea L.

Discovering and harnessing oxidative enzymes for chemoenzymatic synthesis and diversification of anticancer camptothecin analogues

Expeditious Total Syntheses of Camptothecin and 10-Hydroxycamptothecin

An Improved Synthesis of (20S)-Camptothecin and Its Analogue Via an Asymmetric Α-Hydroxylation with a Chiral Organocatalyst

Anticancer effects of a novel class rosin-derivatives with different mechanisms

Synthetic Studies on Camptothecins. Part 3

A Formal Synthesis of Camptothecin Via a Photocatalytic Decarboxylative Radical Addition

Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors

A Concise Total Synthesis of (±)-Camptothecin

Synthesis and anticancer activity of novel quinazolinone-based rhodanines

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Advances in Anti-tumor Application of ROS Enzymatic-mimetic Catalysts

Synthesis, Molecular Modeling, and Biological Evaluation of Quinazoline Derivatives Containing the 1,3,4-Oxadiazole Scaffold As Novel Inhibitors of VEGFR2